Quick Answer
Vaxcyte, Inc. reported Net Income of -$766.63 million for fiscal year 2025.
Vaxcyte, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$766.63M | -65.2% |
| 2024 | -$463.93M | -15.3% |
| 2023 | -$402.27M | -80.0% |
| 2022 | -$223.49M | -123.3% |
| 2021 | -$100.08M | -12.2% |
| 2020 | -$89.22M | -77.5% |
| 2019 | -$50.27M | -70.5% |
| 2018 | -$29.48M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$212.83M | -106.4% | -27.8% |
| June 30, 2025 | -$166.57M | -29.4% | -18.4% |
| March 31, 2025 | -$140.72M | -48.1% | -36.5% |
| September 30, 2024 | -$103.12M | -11.3% | +19.9% |
| June 30, 2024 | -$128.70M | -88.3% | -35.4% |
| March 31, 2024 | -$95.02M | -57.2% | -2.5% |
| September 30, 2023 | -$92.66M | -60.0% | -35.6% |
| June 30, 2023 | -$68.34M | -40.8% | -13.0% |
- Vaxcyte, Inc. showed a decrease of -65.2% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Vaxcyte, Inc.’s net income has declined by 2500.1% (from -$29.48 million to -$766.63 million).
- The most recent figure is from Vaxcyte, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: